Rosiglitazone and Trametinib to treat basal bladder tumors [ATAC-Seq]

ABSTRACT: To investigate the anti-tumor effect of Rosiglitazone+Trametinib in basal bladder cancer, we tested the drug combination in BBN-induced basal tumor mouse model in vivo and BBN-derived tumor cell line BBN963 in vitro.

ORGANISM(S): Mus musculus

PROVIDER: GSE234325 | GEO | 2024/03/15

REPOSITORIES: GEO